Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage

Author： Furukawa Tetsuya   Okada Kazuyoshi   Abe Masanori   Tei Ritsukou   Oikawa Osamu   Maruyama Noriaki   Maruyama Takashi  

Publisher： MDPI

E-ISSN： 1422-0067|16|12|30181-30189

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.16, Iss.12, 2015-12, pp. : 30181-30189

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resistance to Recombinant Human Erythropoietin Therapy in a Rat Model of Chronic Kidney Disease Associated Anemia

By Garrido Patrícia   Ribeiro Sandra   Fernandes João   Vala Helena   Rocha-Pereira Petronila   Bronze-da-Rocha Elsa   Belo Luís   Costa Elísio   Santos-Silva Alice   Reis Flávio  

International Journal of Molecular Sciences, Vol. 17, Iss. 1, 2015-12 ,pp. : 28-28

MDPI

Access to resources Recommend Favorite

Advances in Chronic Kidney Disease

By Parrish Alan R.  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-08 ,pp. : 1314-1314

MDPI

Access to resources Recommend Favorite

NAFLD and Chronic Kidney Disease

By Marcuccilli Morgan   Chonchol Michel  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 562-562

MDPI

Access to resources Recommend Favorite

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

By Boelaert Jente   Schepers Eva   Glorieux Griet   Eloot Sunny   Vanholder Raymond   Lynen Frédéric  

Toxins, Vol. 8, Iss. 11, 2016-10 ,pp. : 312-312

MDPI

Access to resources Recommend Favorite

Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS versus ELISA. Toxins 2016, 8, 149

By Tsikas Dimitrios   Beckmann Bibiana   Araujo Pedro  

Toxins, Vol. 8, Iss. 11, 2016-10 ,pp. : 311-311

MDPI

Access to resources Recommend Favorite